Exclusive

Publication

Byline

Location

Aurobindo Pharma: Strong dose of growth opportunities

New Delhi, Oct. 3 -- Aurobindo Pharma has developed multiple growth opportunities which should play out both in the long term and short term. As the company has commercialised most ventures, its risk ... Read More


Alkem Labs: Hold on till growth gets a new boost

New Delhi, Sept. 26 -- Alkem Labs' revenue grew 8.2 per cent CAGR over FY23-26 to Rs.14,712 crore in FY26, while PAT recorded a CAGR of 32 per cent to Rs.2,351 crore, aided by an improvement in the EB... Read More


A much-needed course correction

New Delhi, Sept. 26 -- IRDAI released a public consultation paper titled "Recalibrating economics of insurance distribution" on September 23, 2026. In the following two days, two listed insurance aggr... Read More


Car insurance with an eye on the sky

New Delhi, Sept. 19 -- Unpredictable weather patterns, the ongoing monsoon season and dense urban infrastructure pose a one-of-a-kind challenge for car owners in India - flood-related damage to vehicl... Read More


Havells holding out for improvements

New Delhi, Sept. 5 -- Havells, a diversified consumer durables manufacturer has reported a pricing-driven revenue growth in the last one year. This while margin improvement remains muted owing to high... Read More


Five investor choices that matter now

New Delhi, Aug. 29 -- Nifty 50 has been unusually range-bound and declined 2 per cent in the last two years compared with a 42 per cent return in the two years prior to this. It is quite clear that ma... Read More


Symbiotec Pharmalab IPO analysis: Key factors investors need to know before subscribing

New Delhi, Aug. 22 -- Symbiotec Pharmalab is a bio-pharmaceutical company with a leading position in fermentation-based hormone and steroid APIs. Its IPO is scheduled for August 24-27. At the upper en... Read More


Freedom to invest with balance sheet strongest in many years

New Delhi, Aug. 15 -- Each quarter, India Inc's profit numbers hog the limelight, while another set of numbers - crucial for sustaining profits for the long term - get lesser attention than they deser... Read More


India Inc throws up a pleasant surprise in Q1 as compared to gloom at the start of the quarter

New Delhi, Aug. 15 -- Under the full glare of the Middle East conflict, India Inc's performance paints an optimistic picture despite relatively flat earnings growth. Of the 4,220 companies that had re... Read More


Molbio IPO: Should investors subscribe?

New Delhi, Aug. 8 -- Molbio is a point-of-care technology (POCT) diagnostics company whose IPO is open from August 10-12. The company developed Truenat, a POCT polymerase chain reaction (PCR) platform... Read More